In triple negative breast cancers (TNBCs), the Y-box binding protein (YB-1) promotes paclitaxel (PTX) resistance by reducing EGR1 levels and cells with lower levels of EGR1 were more resistant to PTX [43]. Here, EGR1 is linked to triple-negative breast carcinoma.